MedPath

Protez Pharmaceuticals, Inc.

Protez Pharmaceuticals, Inc. logo
🇺🇸United States
Ownership
Subsidiary
Established
2003-04-01
Employees
1
Market Cap
-
Website
http://www.protez.com

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

Safety, Potential Efficacy, and Pharmacokinetics of PZ-601 in the Treatment of Complicated Skin and Skin Structure Infection

Phase 2
Completed
Conditions
Skin Infections
Interventions
Drug: Standard of Care
First Posted Date
2008-05-05
Last Posted Date
2009-06-03
Lead Sponsor
Protez Pharmaceuticals, Inc.
Target Recruit Count
99
Registration Number
NCT00671580
Locations
🇺🇸

eStudySite - Sharp Chula Vista, Chula Vista, California, United States

🇺🇸

Novellus Research Site, Long Beach, California, United States

🇺🇸

eStudySite - Tri-City Medical Center, Oceanside, California, United States

and more 11 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.